Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

October 23, 2017

SMITH v. ANTARES PHARMA, INC. et al

Track this case

Case Number:

3:17-cv-08945

Court:

New Jersey

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Michael A. Shipp

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 28, 2020

    Antares Pharma Beats Suit Over 'Vague' Drug Statements

    Antares Pharma Inc. again defeated a proposed securities class action alleging it misled investors about the risks of hypertension, suicide and depression associated with a testosterone medication after a New Jersey federal judge on Tuesday said the company's purported misrepresentations were "vague and general statements of optimism."

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login